Identification of 70 calcium-sensing receptor mutations in hyper- and hypo-calcaemic patients: evidence for clustering of extracellular domain mutations at calcium-binding sites.
The calcium-sensing receptor (CaSR) is a G-protein-coupled receptor that has an extracellular bilobed venus flytrap domain (VFTD) predicted to contain five calcium (Ca(2+))-binding sites. To elucidate the structure-function relationships of the VFTD, we investigated 294 unrelated probands with famil...
| Autori principali: | , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Natura: | Journal article |
| Lingua: | English |
| Pubblicazione: |
2012
|
| _version_ | 1826261581671956480 |
|---|---|
| author | Hannan, F Nesbit, M Zhang, C Cranston, T Curley, A Harding, B Fratter, C Rust, N Christie, P Turner, J Lemos, M Bowl, MR Bouillon, R Brain, C Bridges, N Burren, C Connell, J Jung, H Marks, E McCredie, D Mughal, Z Rodda, C Tollefsen, S Brown, E Yang, J |
| author_facet | Hannan, F Nesbit, M Zhang, C Cranston, T Curley, A Harding, B Fratter, C Rust, N Christie, P Turner, J Lemos, M Bowl, MR Bouillon, R Brain, C Bridges, N Burren, C Connell, J Jung, H Marks, E McCredie, D Mughal, Z Rodda, C Tollefsen, S Brown, E Yang, J |
| author_sort | Hannan, F |
| collection | OXFORD |
| description | The calcium-sensing receptor (CaSR) is a G-protein-coupled receptor that has an extracellular bilobed venus flytrap domain (VFTD) predicted to contain five calcium (Ca(2+))-binding sites. To elucidate the structure-function relationships of the VFTD, we investigated 294 unrelated probands with familial hypocalciuric hypercalcaemia (FHH), neonatal severe primary hyperparathyroidism (NSHPT) or autosomal dominant hypocalcaemic hypercalciuria (ADHH) for CaSR mutations and performed in vitro functional expression studies and three-dimensional modelling of mutations involving the VFTD. A total of 70 different CaSR mutations were identified: 35 in FHH, 10 in NSHPT and 25 in ADHH patients. Furthermore, a CaSR variant (Glu250Lys) was identified in FHH and ADHH probands and demonstrated to represent a functionally neutral polymorphism. NSHPT was associated with a large proportion of truncating CaSR mutations that occurred in the homozygous or compound heterozygous state. Thirty-four VFTD missense mutations were identified, and 18 mutations were located within 10 Å of one or more of the predicted Ca(2+)-binding sites, particularly at the VFTD cleft, which is the principal site of Ca(2+) binding. Mutations of residues 173 and 221, which are located at the entrance to the VFTD cleft binding site, were associated with both receptor activation (Leu173Phe and Pro221Leu) and inactivation (Leu173Pro and Pro221Gln), thereby highlighting the importance of these residues for entry and binding of Ca(2+) by the CaSR. Thus, these studies of disease-associated CaSR mutations have further elucidated the role of the VFTD cleft region in Ca(2+) binding and the function of the CaSR. |
| first_indexed | 2024-03-06T19:23:37Z |
| format | Journal article |
| id | oxford-uuid:1af45bc9-6b99-43d4-bb85-fa1a617918bc |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T19:23:37Z |
| publishDate | 2012 |
| record_format | dspace |
| spelling | oxford-uuid:1af45bc9-6b99-43d4-bb85-fa1a617918bc2022-03-26T10:57:41ZIdentification of 70 calcium-sensing receptor mutations in hyper- and hypo-calcaemic patients: evidence for clustering of extracellular domain mutations at calcium-binding sites.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:1af45bc9-6b99-43d4-bb85-fa1a617918bcEnglishSymplectic Elements at Oxford2012Hannan, FNesbit, MZhang, CCranston, TCurley, AHarding, BFratter, CRust, NChristie, PTurner, JLemos, MBowl, MRBouillon, RBrain, CBridges, NBurren, CConnell, JJung, HMarks, EMcCredie, DMughal, ZRodda, CTollefsen, SBrown, EYang, JThe calcium-sensing receptor (CaSR) is a G-protein-coupled receptor that has an extracellular bilobed venus flytrap domain (VFTD) predicted to contain five calcium (Ca(2+))-binding sites. To elucidate the structure-function relationships of the VFTD, we investigated 294 unrelated probands with familial hypocalciuric hypercalcaemia (FHH), neonatal severe primary hyperparathyroidism (NSHPT) or autosomal dominant hypocalcaemic hypercalciuria (ADHH) for CaSR mutations and performed in vitro functional expression studies and three-dimensional modelling of mutations involving the VFTD. A total of 70 different CaSR mutations were identified: 35 in FHH, 10 in NSHPT and 25 in ADHH patients. Furthermore, a CaSR variant (Glu250Lys) was identified in FHH and ADHH probands and demonstrated to represent a functionally neutral polymorphism. NSHPT was associated with a large proportion of truncating CaSR mutations that occurred in the homozygous or compound heterozygous state. Thirty-four VFTD missense mutations were identified, and 18 mutations were located within 10 Å of one or more of the predicted Ca(2+)-binding sites, particularly at the VFTD cleft, which is the principal site of Ca(2+) binding. Mutations of residues 173 and 221, which are located at the entrance to the VFTD cleft binding site, were associated with both receptor activation (Leu173Phe and Pro221Leu) and inactivation (Leu173Pro and Pro221Gln), thereby highlighting the importance of these residues for entry and binding of Ca(2+) by the CaSR. Thus, these studies of disease-associated CaSR mutations have further elucidated the role of the VFTD cleft region in Ca(2+) binding and the function of the CaSR. |
| spellingShingle | Hannan, F Nesbit, M Zhang, C Cranston, T Curley, A Harding, B Fratter, C Rust, N Christie, P Turner, J Lemos, M Bowl, MR Bouillon, R Brain, C Bridges, N Burren, C Connell, J Jung, H Marks, E McCredie, D Mughal, Z Rodda, C Tollefsen, S Brown, E Yang, J Identification of 70 calcium-sensing receptor mutations in hyper- and hypo-calcaemic patients: evidence for clustering of extracellular domain mutations at calcium-binding sites. |
| title | Identification of 70 calcium-sensing receptor mutations in hyper- and hypo-calcaemic patients: evidence for clustering of extracellular domain mutations at calcium-binding sites. |
| title_full | Identification of 70 calcium-sensing receptor mutations in hyper- and hypo-calcaemic patients: evidence for clustering of extracellular domain mutations at calcium-binding sites. |
| title_fullStr | Identification of 70 calcium-sensing receptor mutations in hyper- and hypo-calcaemic patients: evidence for clustering of extracellular domain mutations at calcium-binding sites. |
| title_full_unstemmed | Identification of 70 calcium-sensing receptor mutations in hyper- and hypo-calcaemic patients: evidence for clustering of extracellular domain mutations at calcium-binding sites. |
| title_short | Identification of 70 calcium-sensing receptor mutations in hyper- and hypo-calcaemic patients: evidence for clustering of extracellular domain mutations at calcium-binding sites. |
| title_sort | identification of 70 calcium sensing receptor mutations in hyper and hypo calcaemic patients evidence for clustering of extracellular domain mutations at calcium binding sites |
| work_keys_str_mv | AT hannanf identificationof70calciumsensingreceptormutationsinhyperandhypocalcaemicpatientsevidenceforclusteringofextracellulardomainmutationsatcalciumbindingsites AT nesbitm identificationof70calciumsensingreceptormutationsinhyperandhypocalcaemicpatientsevidenceforclusteringofextracellulardomainmutationsatcalciumbindingsites AT zhangc identificationof70calciumsensingreceptormutationsinhyperandhypocalcaemicpatientsevidenceforclusteringofextracellulardomainmutationsatcalciumbindingsites AT cranstont identificationof70calciumsensingreceptormutationsinhyperandhypocalcaemicpatientsevidenceforclusteringofextracellulardomainmutationsatcalciumbindingsites AT curleya identificationof70calciumsensingreceptormutationsinhyperandhypocalcaemicpatientsevidenceforclusteringofextracellulardomainmutationsatcalciumbindingsites AT hardingb identificationof70calciumsensingreceptormutationsinhyperandhypocalcaemicpatientsevidenceforclusteringofextracellulardomainmutationsatcalciumbindingsites AT fratterc identificationof70calciumsensingreceptormutationsinhyperandhypocalcaemicpatientsevidenceforclusteringofextracellulardomainmutationsatcalciumbindingsites AT rustn identificationof70calciumsensingreceptormutationsinhyperandhypocalcaemicpatientsevidenceforclusteringofextracellulardomainmutationsatcalciumbindingsites AT christiep identificationof70calciumsensingreceptormutationsinhyperandhypocalcaemicpatientsevidenceforclusteringofextracellulardomainmutationsatcalciumbindingsites AT turnerj identificationof70calciumsensingreceptormutationsinhyperandhypocalcaemicpatientsevidenceforclusteringofextracellulardomainmutationsatcalciumbindingsites AT lemosm identificationof70calciumsensingreceptormutationsinhyperandhypocalcaemicpatientsevidenceforclusteringofextracellulardomainmutationsatcalciumbindingsites AT bowlmr identificationof70calciumsensingreceptormutationsinhyperandhypocalcaemicpatientsevidenceforclusteringofextracellulardomainmutationsatcalciumbindingsites AT bouillonr identificationof70calciumsensingreceptormutationsinhyperandhypocalcaemicpatientsevidenceforclusteringofextracellulardomainmutationsatcalciumbindingsites AT brainc identificationof70calciumsensingreceptormutationsinhyperandhypocalcaemicpatientsevidenceforclusteringofextracellulardomainmutationsatcalciumbindingsites AT bridgesn identificationof70calciumsensingreceptormutationsinhyperandhypocalcaemicpatientsevidenceforclusteringofextracellulardomainmutationsatcalciumbindingsites AT burrenc identificationof70calciumsensingreceptormutationsinhyperandhypocalcaemicpatientsevidenceforclusteringofextracellulardomainmutationsatcalciumbindingsites AT connellj identificationof70calciumsensingreceptormutationsinhyperandhypocalcaemicpatientsevidenceforclusteringofextracellulardomainmutationsatcalciumbindingsites AT jungh identificationof70calciumsensingreceptormutationsinhyperandhypocalcaemicpatientsevidenceforclusteringofextracellulardomainmutationsatcalciumbindingsites AT markse identificationof70calciumsensingreceptormutationsinhyperandhypocalcaemicpatientsevidenceforclusteringofextracellulardomainmutationsatcalciumbindingsites AT mccredied identificationof70calciumsensingreceptormutationsinhyperandhypocalcaemicpatientsevidenceforclusteringofextracellulardomainmutationsatcalciumbindingsites AT mughalz identificationof70calciumsensingreceptormutationsinhyperandhypocalcaemicpatientsevidenceforclusteringofextracellulardomainmutationsatcalciumbindingsites AT roddac identificationof70calciumsensingreceptormutationsinhyperandhypocalcaemicpatientsevidenceforclusteringofextracellulardomainmutationsatcalciumbindingsites AT tollefsens identificationof70calciumsensingreceptormutationsinhyperandhypocalcaemicpatientsevidenceforclusteringofextracellulardomainmutationsatcalciumbindingsites AT browne identificationof70calciumsensingreceptormutationsinhyperandhypocalcaemicpatientsevidenceforclusteringofextracellulardomainmutationsatcalciumbindingsites AT yangj identificationof70calciumsensingreceptormutationsinhyperandhypocalcaemicpatientsevidenceforclusteringofextracellulardomainmutationsatcalciumbindingsites |